eLaws | eCases | United States Code | Federal Courts |
Home » 2010 Issues » 75 FR (08/10/2010) » 2010-19637. Advancing the Development of Medical Products Used In the Prevention, Diagnosis, and Treatment of Neglected Tropical Diseases; Public Hearing; Change of Hearing Date and Location

  2010-19637. Advancing the Development of Medical Products Used In the Prevention, Diagnosis, and Treatment of Neglected Tropical Diseases; Public Hearing; Change of Hearing Date and Location  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing a change in date and location for the upcoming public hearing entitled “Advancing the Development of Medical Products Used in the Prevention, Diagnosis, and Treatment of Neglected Tropical Diseases.” A new date and address are given for those attending the public hearing.

    DATES:

    The public hearing will be held on September 23, 2010, from 9 a.m. to 5 p.m. However, depending on the level of public participation, the meeting may be extended or it may end early.

    ADDRESSES:

    The public hearing will be held at the National Labor College, 10000 New Hampshire Ave., Silver Spring, MD 20903. Persons attending the public hearing are advised that FDA is not responsible for providing access to electrical outlets.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ann M. Staten, Office of Critical Path Programs, Food and Drug Administration, 10903 New Hampshire Ave., Bldg., 32, rm. 4106, Silver Spring, MD 20993-0002, 301-796-8504, Ann.Staten@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    In the Federal Register of July 20, 2010 (75 FR 42103), FDA published a notice announcing a public hearing that is intended to solicit general views and information from interested persons on issues related to advancing the development of medical products (drugs, biological products, and medical devices) used in the prevention, diagnosis, and treatment of neglected tropical diseases. The registration dates from the July 20, 2010, notice have not changed. Individuals interested in making an oral presentation should submit a notice of participation by September 1, 2010. All others attending the public hearing are requested to register by September 17, 2010.

    Because of a scheduling conflict with the published date, FDA is announcing in this notice a new date and location for the public hearing.

    II. New Date and Location for the Pubic Hearing

    The new date will be September 23, 2010 (see DATES). The new location will be the National Labor College (see ADDRESSES). Directions and information on parking, accommodations, and transportation options can be found at http://www.nlc.edu/​about/​maps-and-directions.

    Start Signature
    Start Printed Page 48357

    Dated: August 4, 2010.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2010-19637 Filed 8-9-10; 8:45 am]

    BILLING CODE 4160-01-S

Visit the Official Version
Leave a Comment

Document Information

Comments Received:
0 Comments
Published:
08/10/2010
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2010-19637
Dates:
The public hearing will be held on September 23, 2010, from 9 a.m. to 5 p.m. However, depending on the level of public participation, the meeting may be extended or it may end early.
Pages:
48356-48357 (2 pages)
Docket Numbers:
Docket No. FDA-2010-N-0364
PDF File:
2010-19637.pdf